Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $20.0700 (-0.69%) ($19.5400 - $20.7500) on Tue. Jan. 24, 2006. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.49% (three month average) | RSI | 67 | Latest Price | $20.0700(-0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) QQQ(7%) EEM(6%) IWM(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.245% in a week (0% probabilities). SHY(-4%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.245% (StdDev 6.49%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $20.52(-2.19%) | 10 Day Moving Average | $20.19(-0.59%) | 20 Day Moving Average | $18.98(5.74%) | To recent high | -10.4% | To recent low | 78.4% | Market Cap | $3.541b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |